ABT - Class Action Against Abbott's Glucerna Products Proceeds in Federal Court | Benzinga
A California federal judge has reportedly allowed litigation to proceed against Abbott Laboratories (NYSE:ABT) regarding its Glucerna shakes and nutritional powders.
The lawsuit claims these products, marketed as suitable for people with diabetes, contain harmful ingredients.
U.S. District Judge P. Casey Pitts in San Jose largely denied Abbott’s motion to dismiss the proposed class action, stating that consumers had provided sufficient evidence to support their claims that Glucerna, which is labeled as “scientifically designed for people with diabetes,” contains sucralose and other additives that some studies indicate could have adverse health effects.
Related: Abbott Faces Lawsuit As Grandmother Questions PediaSure’s Height Growth Claims.
Judge Pitts did grant Abbott’s motion to dismiss ...